Brendan Dickinson
General Partner / East Coast
Canaan Partners
Canaan General Partner leading the firm’s fintech practice, with emphasis on fintech infrastructure, platforms, products, and insurance.
Managing Partner, Canaan Partners’ Axcelius·Canaan Partners
Professional summary
Dennis Podlesak is Managing Partner of Canaan Partners’ Axcelius and Chairman and CEO of Transposon Therapeutics, which he co-founded. He is also Chairman of Syndax Pharmaceuticals and an Advisory Partner to Domain Associates, where he joined as a Partner in 2007. His investment and operating track record includes Tobira Therapeutics, Avanir Pharmaceuticals, RightCare Solutions, Peninsula Pharmaceuticals, Cerexa, Calixa Therapeutics and Corthera.
Selected portfolio companies the partner has backed
Career, education, and skills
12 more profiles